ArticleInternational journal of ophthalmology2022

Evaluation of nintedanib as a new postoperative antiscarring agent in experimental extraocular muscle surgery.

Gozde Bicaklioglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.